Cover Image
市場調查報告書

移植診斷的全球市場分析:各技術 (分子,PCR/定序型,非分子化驗,血清學,MLC),各產品 (試劑及消耗品,設備,服務,軟體),市場區隔預測

Transplant Diagnostic Market Analysis By Technology (Molecular: PCR/Sequencing-based; Non-molecular assays: Serological, MLC), By Product (Reagents and Consumables, Instrument, Services and Software) And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 368024
出版日期 內容資訊 英文 93 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
移植診斷的全球市場分析:各技術 (分子,PCR/定序型,非分子化驗,血清學,MLC),各產品 (試劑及消耗品,設備,服務,軟體),市場區隔預測 Transplant Diagnostic Market Analysis By Technology (Molecular: PCR/Sequencing-based; Non-molecular assays: Serological, MLC), By Product (Reagents and Consumables, Instrument, Services and Software) And Segment Forecasts To 2024
出版日期: 2016年07月25日 內容資訊: 英文 93 Pages
簡介

本報告提供全球移植診斷市場相關調查,彙整產業預測,以及各技術,各產品,各用途,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
  • 推動市場的要素分析
  • 阻礙市場的要素分析
  • 優先的主要機會
  • 波特五力分析模式
  • PESTEL分析
  • 企業的市場佔有率分析
  • 價值鏈分析

第4章 技術預測

  • 各技術市場收益佔有率
  • 分子化驗
  • 非分子化驗

第5章 產品預測

  • 各產品市場收益佔有率
  • 試劑及消耗品
  • 設備
  • 服務及軟體產品

第6章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • F. Hoffmann La-Roche AG.
  • Abbott Laboratories, Inc.
  • Bio-Rad Laboratories, Inc.
  • Immucor Transplant Diagnostics, Inc.
  • Omixon Ltd. ?7.8.1 Company Overview

圖表

目錄

The global Transplant Diagnostic Market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fueling the demand for transplant diagnostics.

Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.

In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe.

Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe.

Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at alower costare anticipated to attract patients worldwide to this region for transplant procedures.

In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024.

Further key findings from the study suggest:

The PCR-based molecular assay captured the largest share of the overall market in 2015. The large market share was mainly attributed to the extensive adoption of the PCR technique in HLA typing.

The sequencing-based typing segment is anticipated to witness significant growth rate from 2016 to 2024. The escalation in the adoption of next generation sequencing (NGS) is the major factor expected to drive the growth of this segment during the forecast period.

The integration of sequencing with serological typing enhances diagnostic outcomes and, hence is expected to augment the growth of the sequencing segment during the forecast period

The reagents and consumables segment accounted for the largest market share in 2015. This large share is mainly attributed to the repeat purchase of these products.

North America captured the largest market share of around 38% in 2015 and is expected to maintain its dominance throughout the forecast period. Well-established research infrastructure, the increasing healthcare expenditure, high adoption rate ofthe advanced diagnostic techniques, and the growing R&D activities are some of the factors supporting the growth of the market in the region.

Asia Pacific is expected to witness significant growth during the forecast period owing to the expanding research opportunities, the increasing health care expenditure, and the rising awareness of organ donation in the region.

The booming medical tourism industry offers further growth opportunities for the market in Asia Pacific

Some major players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc.,Qiagen N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc., and Omixon Ltd.

Table of Content

Chapter 1: Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Country wide market: Base estimates
    • 1.1.2 Global market: CAGR calculation
  • 1.2 Research Scope & Assumptions
  • 1.3 List of Data Sources

Chapter 2: Executive Summary

Chapter 3: Transplant Diagnostics Industry Outlook

  • 3.1 Market segmentation
  • 3.2 Market size and growth prospects
  • 3.3 Transplant Diagnostics:market dynamics
  • 3.4 Market driver analysis
  • 3.5 Market restraint analysis
  • 3.6 Key opportunities prioritized
  • 3.7 Transplant Diagnostics industry analysis - Porter's Five Forces Model
  • 3.8 Transplant Diagnostic market - PESTEL analysis
  • 3.9 Transplant Diagnostics : company market share analysis, 2014
  • 3.10 Value Chain Analysis

Chapter 4: Transplant Diagnostics Technology Outlook

  • 4.1 Transplant Diagnostic market revenue share by Technology, 2014 & 2024, % share
  • 4.2 Molecular Assay
    • 4.2.1 Molecular Assay, Market Revenue, by type (USD Million), 2014 - 2024
    • 4.2.2 PCR-based Assay
      • 4.2.2.1 PCR-based Assay, Market Revenue, by type (USD Million), 2014 - 2024
    • 4.2.3 Sequencing-based Assay
      • 4.2.3.1 Sequencing-based Assay, Market Revenue, by type (USD Million), 2014 - 2024
  • 4.3 Non-molecular Assay
    • 4.3.1 Non-molecular Assay Market Revenue, 2014 to 2024 (USD Million)
    • 4.3.2 Serological Assay
      • 4.3.2.1 Serological Assay Market Revenue, 2014 to 2024 (USD Million)
    • 4.3.3 MLC Assay
      • 4.3.3.1 MLC Assay Market Revenue, 2014 to 2024 (USD Million)

Chapter 5: Transplant Diagnostics Product Outlook

  • 5.1 Transplant Diagnostic market revenue share by product , 2014 & 2024, % share
  • 5.2 Reagents and Consumables
    • 5.2.1 Reagents and Consumables Market Revenue, (USD Million), 2014 - 2024
  • 5.3 Instruments
    • 5.3.1 Instruments market revenue, 2014 to 2024 (USD Million)
  • 5.4 Services and Software Product
    • 5.4.1 Services and Software Market revenue, 2014 to 2024 (USD Million)

Chapter 6: Transplant Diagnostic market Regional Outlook

  • 6.1 Transplant Diagnostic market share, by region, 2014 & 2024.
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
  • 6.3 Europe
    • 6.3.1 UK
    • 6.3.2 Germany
  • 6.4 Asia Pacific
    • 6.4.1 Japan
    • 6.4.2 India
  • 6.5 Latin America
    • 6.5.1 Brazil
    • 6.5.2 Mexico
  • 6.6 Middle East and Africa (MEA)
    • 6.6.1 South Africa

Chapter 7: Competitive Landscape

  • 7.1 Thermo Fisher Scientific, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Qiagen N.V.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Illumina, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 F. Hoffmann La-Roche AG.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 Abbott Laboratories, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Bio-Rad Laboratories, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Immucor Transplant Diagnostics, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 Omixon Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives

List of Tables

  • TABLE 1: Transplant Diagnostic Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2: Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 3: Transplant Diagnostic Market Revenue, by Region, 2014 - 2024 (USD Million)
  • TABLE 4: Transplant Diagnostics - Key market driver analysis
  • TABLE 5: Transplant Diagnostics - Key market restraints analysis
  • TABLE 6: North America Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 7: North America Transplant Diagnostic Market Revenue, by Product, 2014 - 2024 (USD Million)
  • TABLE 8: U.S. Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 9: U.S. Transplant Diagnostic Market Revenue, by Product, 2014 - 2024 (USD Million)
  • TABLE 10: Canada Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 11: Canada Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 12: Europe Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 13: Europe Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 14: UK Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Billion)
  • TABLE 15: UK Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 16: Germany Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 17: Germany Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 18: Asia Pacific Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 19: Asia Pacific Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 20: Japan Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 21: Japan Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 22: India Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 23: India Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 24: Latin America Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 25: Latin America Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 26: Brazil Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 27: Brazil Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 28: Mexico Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 29: Mexico Transplant Diagnostic Market Revenue, by Product , 2014 - 2024 (USD Million)
  • TABLE 30: MEA Transplant Diagnostic Market Revenue, by Technology, 2014 - 2024 (USD Million)
  • TABLE 31: MEA Transplant Diagnostic Market Revenue, by Product, 2014 - 2024 (USD Million)
  • TABLE 32: South Africa Transplant Diagnostic Market Revenue,by Technology, 2014 - 2024 (USD Million)
  • TABLE 33: South Africa Transplant Diagnostic Market Revenue, by Product, 2014 - 2024 (USD Million)
Back to Top